In vivo pharmacokinetics of ginsenoside compound K mediated by gut microbiota
PLOS ONE · 23.08.2024 · 19 (8) · e0307286
DOI: 10.1371/journal.pone.0307286 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 23.08.2024. Verfasst von Ming-Si Deng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stomatology, the Third Xiangya Hospital of Central South University, Central South University, Changsha, China. Hauptthemen laut MEDLINE: Ginsenosides, Gastrointestinal Microbiome. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Scientific Foundation of China, the Hunan Provincial Natural Science Foundation of China, the Scientific Research Program of Furong laboratory.
Abstract (Originalsprache)
Ginsenoside Compound K (GCK) is the main metabolite of natural protopanaxadiol ginsenosides with diverse pharmacological effects. Gut microbiota contributes to the biotransformation of GCK, while the effect of gut microbiota on the pharmacokinetics of GCK in vivo remains unclear. To illustrate the role of gut microbiota in GCK metabolism in vivo , a systematic investigation of the pharmacokinetics of GCK in specific pathogen free (SPF) and pseudo-germ-free (pseudo-GF) rats were conducted. Pseudo-GF rats were treated with non-absorbable antibiotics. Liquid chromatography tandem mass spectrometry (LC–MS/MS) was validated for the quantification of GCK in rat plasma. Compared with SPF rats, the plasma concentration of GCK significantly increased after the gut microbiota depleted. The results showed that GCK absorption slowed down, T max delayed by 3.5 h, AUC 0-11 increased by 1.3 times, CL z/F decreased by 0.6 times in pseudo-GF rats, and C max was 1.6 times higher than that of normal rats. The data indicated that gut microbiota played an important role in the pharmacokinetics of GCK in vivo .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Stomatology, the Third Xiangya Hospital of Central South University, Central South University, Changsha, China.
- Department of Orthodontics, Changsha Stomatological Hospital, Hunan University of Chinese Medicine, Changsha, China.
- Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China.
- Department of Pharmacognosy, School of Pharmacy, Hunan University of Chinese Medicine, Changsha, Hunan, China.
- Department of Spinal Surgery, the Third Xiangya Hospital of Central South University, Central South University, Changsha, China.
- FuRong Laboratory, Changsha, Hunan, China.
ORCID-Profile: Zheng-Guang Wang
Förderung
- the National Natural Scientific Foundation of China
- the Hunan Provincial Natural Science Foundation of China
- the Scientific Research Program of Furong laboratory
- the Scientific Research Project of Department of Education of Hunan Province
Zitieren
APA
Deng, M. S., Huang, S. T., Xu, Y. N., Shao, L., Wang, Z. G., Chen, L. J., & Huang, W. H. (2024). In vivo pharmacokinetics of ginsenoside compound K mediated by gut microbiota. PLOS ONE, 19(8), e0307286. https://doi.org/10.1371/journal.pone.0307286
Vancouver
Deng MS, Huang ST, Xu YN, Shao L, Wang ZG, Chen LJ, et al. In vivo pharmacokinetics of ginsenoside compound K mediated by gut microbiota. PLOS ONE. 2024;19(8):e0307286. doi:10.1371/journal.pone.0307286
BibTeX
@article{Deng2024,
author = {Deng, Ming-Si and Huang, Su-Tian-Zi and Xu, Ya-Ni and Shao, Li and Wang, Zheng-Guang and Chen, Liang-Jian and Huang, Wei-Hua},
title = {In vivo pharmacokinetics of ginsenoside compound K mediated by gut microbiota},
journal = {PLOS ONE},
year = {2024},
volume = {19},
number = {8},
pages = {e0307286},
doi = {10.1371/journal.pone.0307286}
}
EUVIMED